pregabalin
Lyrica to be made class C drug in Northern Ireland
April 1, 2019Sales and Marketing Lyrica, Northern Ireland, class c, illegal drugs, pain, pregabalin
Pregabalin – sold under the brand name Lyrica – will now be treated as a class C drug in Northern …
Pfizer loses UK patent infringement case over $5.1bn drug
October 13, 2016Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, patent infringement, pregabalin
Pfizer has been dealt a significant blow as the UK Court of Appeal has rejected the company’s patent infringement claims …
High Court rules against Pfizer in Lyrica patent case
September 10, 2015Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin
The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
Pfizer offers to pay for UK Lyrica switches
August 13, 2015Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin
Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …
Big-name generics among new CHMP recommendations
April 27, 2015Sales and Marketing CHMP, EMA, European Medicines Agency, Lyrica, pregabalin
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended 11 new medicines for approval, among them several …
Generic version of Pfizer’s Lyrica launched
March 25, 2015Sales and Marketing CCG, Lyrica, NHS, Pfizer, consilient health, pregabalin, rewisca
A UK pharma firm has launched a cut-price version of Pfizer’s Lyrica along with a bespoke supply chain to ensure …
New Lyrica formulation effective in trials
December 19, 2014Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles
Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …
Pfizer drops 15 pipeline projects
March 1, 2011Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin
Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …
Latest content
